Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Synthorx, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Synthorx, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Synthorx, Inc. since 2005.
The reporting company's ticker symbol is THOR. The reporting company's CIK number is 1609727.
The total value of stock buying since 2005 is $148,000,017.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-12-11||Avalon X Spv, L.p. (10% Owner)||Buy||545,455||11.00||6,000,005|
|2018-12-11||Orbimed Capital Gp Vii Llc (10% Owner)||Buy||1,363,636||11.00||14,999,996|
|2018-12-11||Reardon Tighe (Acting Chief Financial Officer)||Buy||545,455||11.00||6,000,005|
|2018-12-11||Lichter Jay (Director)||Buy||545,455||11.00||6,000,005|
|2018-12-11||Thompson Peter A. (Director)||Buy||1,363,636||11.00||14,999,996|
|2018-12-11||Ra Capital Healthcare Fund Lp||Buy||4,545,455||11.00||50,000,005|
Insider trading activities including stock purchases, stock sales, and option exercises of THOR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Synthorx, Inc. (symbol THOR, CIK number 1609727) see the Securities and Exchange Commission (SEC) website.